pharmaceutical-articles meeting-global-demands-for-viral-vector-based-vaccines 
Drug Discovery World
SEPTEMBER 6, 2022
This statement is backed up by an article in Blood Cancer Journal 1 which outlines CAR-T cell therapies’ struggle to infiltrate solid tumours due to their immunosuppressive nature and the physical barriers they present. . There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs.
XTalks
SEPTEMBER 14, 2020
“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine. The price of that prize is incalculable.
Expert insights. Personalized for you.
52 
Let's personalize your content